Regensburg, Germany

Luka Krampert

This inventor holds 1 USPTO granted patent. Top assignee: The University of British Columbia. Active years: 2026.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Luka Krampert. Retrieved from https://idiyas.com/inventor/luka-krampert

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Calculating rank

Average Co-Inventor Count = 1.0


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Luka Krampert: Innovator in Antiviral Research

Introduction

Luka Krampert is a notable inventor based in Regensburg, Germany. He has made significant contributions to the field of antiviral research, particularly through his innovative patent. His work focuses on developing antiviral agents that can combat viral infections, including those caused by coronaviruses and flaviviruses.

Latest Patents

Krampert holds a patent titled "Antiviral agents, uses thereof and methods for their preparation." This patent details the use of cladoniamides and their derivatives as antiviral agents. The disclosure emphasizes the potential of these compounds in treating viral infections, showcasing Krampert's commitment to advancing medical science.

Career Highlights

Luka Krampert is affiliated with the University of British Columbia, where he continues to engage in groundbreaking research. His academic background and professional endeavors have positioned him as a key figure in the field of antiviral drug development.

Collaborations

Krampert collaborates with François Jean, enhancing the scope and impact of his research. Their partnership exemplifies the importance of teamwork in scientific innovation.

Conclusion

Luka Krampert's contributions to antiviral research through his patent and collaboration with François Jean highlight his dedication to improving public health. His work is a testament to the vital role of inventors in addressing global health challenges.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…